Market Overview

Akorn Shares Rally Following Increased Price Target

Related AKRX
Earnings Scheduled For February 26, 2015
Jefferies Weighs In On Specialty Pharmaceuticals After Management Meetings, Raises Price Targets On 5 Stocks
Akorn (AKRX) Q4 2014 Results - Earnings Call Webcast (Seeking Alpha)

Shares of Akorn (NASDAQ: AKRX) were up nearly 10 percent Tuesday around $36.50 following the release of a Needham note in which the price target for the company was raised from $30 to $40.

The note cited a "game changing" effect if Akorn matches Taro Pharmaceutical Industries' recent price increases in topical generics.

Shares are currently up 5.25 percent at $34.99.

Latest Ratings for AKRX

Jan 2015JefferiesMaintainsBuy
Nov 2014CRT CapitalUpgradesFairly ValuedBuy
Oct 2014Wallachbeth CapitalInitiates Coverage onBuy

View More Analyst Ratings for AKRX
View the Latest Analyst Ratings

Posted-In: NeedhamAnalyst Color News Price Target Analyst Ratings


Related Articles (AKRX)

Around the Web, We're Loving...

Get Benzinga's Newsletters